Relative to the non-DFU group, DFU patients had worse metabolic and vascular profiles, with higher prevalence rates of retinopathy, neuropathy, stroke, and hypertension, as well as significant abnormalities in laboratory measures such as glycohemoglobin, CRP, creatinine, and hemoglobin. This evidence concerns the gene CRP and hypertensive disorder.